No Data
No Data
CervoMed Inc. (NASDAQ:CRVO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
D. Boral Capital Initiates Coverage On CervoMed With Buy Rating, Announces Price Target of $34
CervoMed Is Maintained at Buy by Chardan Capital
CervoMed Price Target Maintained With a $55.00/Share by Chardan Capital
CervoMed Analyst Ratings
CervoMed | 8-K: CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
No Data
No Data
I Am 102927471 :